CAPR
Beyond's analysis on CAPR
- — ClaimsFiler urges investors with over $100,000 in losses to file lead plaintiff applications by September 28, 2026 in the securities class action against Capricor Therapeutics
- — Capricor Therapeutics faces critical legal deadline for investors seeking lead roles in securities fraud class action
- — Capricor Therapeutics faces increasing legal pressure as multiple law firms launch class action lawsuits for securities law violations
- — Capricor Therapeutics faces growing legal pressure as investors approach deadline for class action leadership amidst FDA review uncertainties
- — Law firm Faruqi & Faruqi calls for lead plaintiffs in Capricor Therapeutics securities class action ahead of September 28 deadline
- — Legal deadline looms for Capricor Therapeutics investors as class action lawsuit seeks lead plaintiffs for securities fraud claims
- — Capricor Therapeutics faces a looming lead plaintiff deadline that could shape the outcome of its securities class action lawsuit
- — Rosen Law Firm alerts Capricor Therapeutics investors of September 2 lead plaintiff deadline in securities fraud class action
- — Capricor Therapeutics faces a class‑action securities lawsuit alleging violations of exchange‑act provisions, triggering potential legal costs and investor scrutiny
- — SBS Law invites investors to lead a securities‑fraud class action against Capricor Therapeutics, highlighting a broader pattern of similar shareholder‑rights actions
- — ClaimsFiler alerts Capricor Therapeutics investors with over $100k losses to file lead plaintiff applications by September 28, 2026
- — Capricor Therapeutics faces a class-action securities lawsuit alleging violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934
Recent news mentioning CAPR
- — Capri shares jump as potential buyers circle luxury fashion group
- — CAPR Class Action: Capricor Therapeutics Investors are Notified of the Upcoming September 28 Deadline in Ongoing Securities Fraud Class Action over Clinical Data
- — CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
- — Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
- — 1 WEEK CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- — CAPR 1-WEEK DEADLINE ALERT: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
- — Capri Sees Second-Half Growth as Michael Kors Reset Gains Traction
- — Jennifer Ashcraft of Capriotti's Named IFA Franchisee of the Year
- — Publication of Scheme Document for Acquisition of Capricorn Energy plc
- — Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
- — Capricor Therapeutics, Inc. Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending September 28, 2026 Lead Plaintiff Deadline
- — Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit